Cibus, Inc. (NASDAQ:CBUS) Sees Large Growth in Short Interest

Cibus, Inc. (NASDAQ:CBUS) was the recipient of a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 2,360,000 shares, an increase of 5.8% from the December 31st total of 2,230,000 shares. Currently, 12.1% of the shares of the company are short sold. Based on an average daily trading volume, of 165,400 shares, the short-interest ratio is currently 14.3 days.

Cibus Trading Down 2.4 %

NASDAQ:CBUS opened at $2.49 on Monday. The firm has a fifty day simple moving average of $3.20 and a 200-day simple moving average of $4.76. The company has a market capitalization of $65.89 million, a P/E ratio of -0.11 and a beta of 1.85. Cibus has a 12 month low of $2.16 and a 12 month high of $23.18.

Cibus (NASDAQ:CBUS) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.89) by $0.95. The firm had revenue of $1.67 million for the quarter, compared to analysts’ expectations of $0.47 million. Cibus had a negative net margin of 10,724.78% and a negative return on equity of 28.17%. During the same quarter last year, the company earned ($1.59) EPS. Equities analysts forecast that Cibus will post -2.96 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on CBUS. Canaccord Genuity Group cut their price objective on shares of Cibus from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Wednesday, January 22nd. HC Wainwright reissued a “buy” rating and set a $25.00 price target on shares of Cibus in a research note on Monday, November 11th.

Institutional Investors Weigh In On Cibus

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. HighTower Advisors LLC raised its stake in shares of Cibus by 20.6% in the third quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock valued at $52,000 after acquiring an additional 2,750 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Cibus by 14.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 49,285 shares of the company’s stock valued at $161,000 after purchasing an additional 6,276 shares during the period. SG Americas Securities LLC purchased a new position in shares of Cibus during the third quarter worth approximately $33,000. B. Riley Wealth Advisors Inc. purchased a new stake in shares of Cibus in the third quarter valued at about $44,000. Finally, Virtu Financial LLC purchased a new stake in Cibus during the 3rd quarter valued at approximately $48,000. 33.81% of the stock is owned by hedge funds and other institutional investors.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.